Animal protein-free media for cultivation of cells

US9809796B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9809796-B2
Application numberUS-201715598406-A
CountryUS
Kind codeB2
Filing dateMay 18, 2017
Priority dateOct 29, 2004
Publication dateNov 7, 2017
Grant dateNov 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for expressing a target protein, comprising the steps of: a) providing a culture of cells into which a nucleic acid comprising a sequence encoding the target protein has been introduced; b) culturing the cells in an animal protein-free cell culture medium comprising putrescine and at least one protein hydrolysate, wherein the hydrolysate is derived from a plant or yeast, and wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 0.5 to about 10 mg/L. 2. The method of claim 1 , wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 2 to about 8 mg/L. 3. The method of claim 1 , wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 2 to about 5 mg/L. 4. The method of claim 1 , wherein the putrescine is from a different source than the protein hydrolysate. 5. The method of claim 1 , wherein the target protein is selected from the group consisting of a biologically active part of a blood coagulation factor, a biologically active part of a protein involved in the production of red blood cells and angiogenesis, and a monoclonal antibody. 6. The method of claim 5 , wherein the target protein is Factor VIII or erythropoietin. 7. The method of claim 6 , wherein the target protein is Factor VIII. 8. The method of claim 1 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cell, bacterial cell, and yeast cells. 9. The method of claim 8 , wherein the mammalian cells are CHO or BHK cells. 10. The method of claim 1 , wherein the cell is a CHO cell and the target protein is Factor VIII, or the cell is a BHK cell and the target protein is erythropoietin, or the cell is an Epstein Barr virus transformed immortalized human B cell and the target protein is a human antibody. 11. The method of claim 10 , wherein the cell is a CHO cell and the target protein is Factor VIII. 12. The method of claim 1 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion-cultivation, and chemostat-cultivation. 13. The method of claim 1 , wherein the animal protein-free cell culture medium further comprises cadaverine, spermidine, spermine, agmatine, or ornithine, or a combination thereof. 14. The method of claim 1 , wherein the protein hydrolysate is derived from cereal or soy. 15. The method of claim 1 , wherein the protein hydrolysate is soy hydrolysate in a concentration ranging from about 0.5 to 30 mg/L. 16. The method of claim 1 , wherein the protein hydrolysate is present in the animal protein-free cell culture medium in a total concentration ranging from about 0.05 (w/v) to about 5% (w/v) for all protein hydrolysates. 17. The method of claim 1 , wherein the cells express the target protein. 18. The method of claim 1 , further comprising the step of isolating the target protein from the animal protein-free cell culture medium. 19. The method of claim 18 , wherein the target protein is Factor VIII.

Assignees

Inventors

Classifications

  • Medium free of human- or animal-derived components · CPC title

  • C12N5/0043Primary

    Medium free of human- or animal-derived components · CPC title

  • from fungi, e.g. yeasts · CPC title

  • Amines, e.g. putrescine · CPC title

  • Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells (oocytes C12N5/0609) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9809796B2 cover?
The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as rec…
Who is the assignee on this patent?
Baxalta Inc, Baxalta GmbH
What technology area does this patent fall under?
Primary CPC classification C12N5/0043. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).